Investment Rating - The report indicates a positive outlook for the maternal and infant industry, driven by supportive policies and expected growth in consumer spending [4][6]. Core Insights - The report emphasizes the transition of China's fertility policy towards comprehensive support for childbirth, which is expected to enhance consumer confidence and spending in the maternal and infant sector [4][17]. - The maternal and infant market has shown resilience, with a compound annual growth rate (CAGR) exceeding 15% from 2018 to 2024, despite a decline in birth rates [6][32]. - The rise of domestic brands in the maternal and infant sector is notable, with significant market share gains in various sub-sectors [6][37]. Summary by Sections 1. Policy Promotion of Fertility - China's fertility policy has evolved from encouraging childbirth to comprehensive support, with various measures being implemented to boost birth rates [4][10]. - The government is focusing on creating a "fertility-friendly" society, with financial incentives and support services being rolled out across different regions [17][18]. 2. Market Growth and Consumer Trends - Despite a decline in newborn numbers, the maternal and infant market is experiencing growth due to consumption upgrades and the diversification of product offerings [6][32]. - The market size is projected to reach approximately 762.99 billion yuan by 2024, reflecting a year-on-year growth of 15% [31]. 3. Beneficiary Industries and Companies - Various sectors are expected to benefit from the growth in the maternal and infant market, including pharmaceuticals, food and beverage, apparel, and household goods [6][41]. - Key companies highlighted include: - Pharmaceuticals: Jinxin Reproductive, LIZHU Group, and BGI Genomics [6][41]. - Dairy: Yili Group and China Feihe [6][42]. - Apparel: Semir and Anta [6][49]. - Household goods: Bear Electric [6][61]. 4. Competitive Landscape - The report notes an improvement in the competitive landscape, with domestic brands gaining market share across various segments, including infant formula and baby care products [6][37]. - The concentration ratio (CR10) for domestic brands has significantly increased, indicating a shift in market dynamics favoring local players [6][37].

Core Viewpoint - Chengdu Pregnant and Infant World Co., Ltd. has completed its listing guidance report and plans to list on the Beijing Stock Exchange, with Guosen Securities as the guidance institution [2] Financial Performance - In 2024, the company achieved operating revenue of 1.038 billion yuan, a year-on-year increase of 39.71% [3] - The net profit attributable to shareholders was 120.22 million yuan, up 26.92% year-on-year [3] - The gross profit margin was 20.09%, down from 22.16% in the previous year [3] - Basic earnings per share increased to 0.33 yuan from 0.26 yuan, reflecting a growth of 26.92% [3] Ownership Structure - The actual controllers of the company are Jiang Dabin and Wang Weijian, with Jiang holding 5.71% of the shares directly [4] - Together, Jiang and Wang indirectly hold 68.27% of the company through their control of Chengdu Junlong, which gives them a combined voting power of 80.40% [4] Company Background - Founded in 2016, Chengdu Pregnant and Infant World is a digital innovation-driven mother and baby chain enterprise, focusing on professional services to support the sustainable development of maternal and infant operators [2]